Panel Discussion: Regulatory Translational Science Focused on Commercialization Challenges for Surface Modification and their Characterization: SIG-SQUARED
Timeslot: Thursday, April 4, 2019 - 1:45pm to 3:45pm
Room: Yakima 2
This session will illuminate the tools, standards, and approaches to Surface Characterization leading to the assessment of the safety, effectiveness, quality, toxicity, public health impact, and performance of FDA-regulated surface modified products. Although this topic is focused on the Surface Modification and Characterization combining perspectives with the Biomaterials and Medical Devices Commercialization SIG, the session can inform a broad audience on the demands of regulatory translational science when developing a modification to a surface (such as nano-texturing or drug coatings) to commercial use. We will examine how Regulatory Science can be different from the science of biomaterials research.
Abstracts will be available for download on April 3, 2019.
1:45 PM 261. Invited Speaker,
2:15 PM 262. Invited Speaker,
2:45 PM 263. Invited Speaker,
3:15 PM 264. Invited Speaker